UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 74

Sortiert nach

Factors associated with quality of life in Italian children and adolescents with IBD

Scientific reports, 2021-09, Vol.11 (1), p.18076-18076, Article 18076

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD Registry

Journal of pediatric gastroenterology and nutrition, 2018-06, Vol.66 (6), p.920-925

2018

Link zum Volltext

Verfügbarkeit prüfen

Treat-to-Target in Pediatric Inflammatory Bowel Disease: What Does the Evidence Say?

Paediatric drugs, 2020-10, Vol.22 (5), p.463-472

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety of Biological Therapy in Children With Inflammatory Bowel Disease

Journal of pediatric gastroenterology and nutrition, 2021-05, Vol.72 (5), p.736-741

2021

Link zum Volltext

Verfügbarkeit prüfen

Natural History of Anemia and Efficacy and Safety of Oral Iron Therapy in Children Newly Diagnosed With Inflammatory Bowel Disease

Journal of pediatric gastroenterology and nutrition, 2023-06, Vol.76 (6), p.771-775

2023

Link zum Volltext

Verfügbarkeit prüfen

Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease

Inflammatory bowel diseases, 2023-07, Vol.29 (7), p.1057-1064

2023

Link zum Volltext

Verfügbarkeit prüfen

Is Fecal Calprotectin a Useful Marker for Small Bowel Crohn Disease?

Journal of pediatric gastroenterology and nutrition, 2021-08, Vol.73 (2), p.242-246

2021

Link zum Volltext

Verfügbarkeit prüfen

A Treat-to-Target Strategy Guided by Pan-Enteric Evaluation in Children With Crohn’s Disease Improves Outcomes at 2 Years

Inflammatory bowel diseases, 2023-08

2023

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Long‐term Clinical and Endoscopic Remission in Children With Crohn Disease Treated With Infliximab

Journal of pediatric gastroenterology and nutrition, 2019-06, Vol.68 (6), p.841-846

2019

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory Bowel Disease-Unclassified in Children: Diagnosis and Pharmacological Management

Paediatric drugs, 2017-04, Vol.19 (2), p.113-120

2017

Link zum Volltext

Verfügbarkeit prüfen

Mucosal healing in Crohn's disease: new insights

Expert review of gastroenterology & hepatology, 2020-05, Vol.14 (5), p.335-345

2020

Link zum Volltext

Verfügbarkeit prüfen

Quality of life in long term survivors of pediatric intestinal transplantation compared with liver transplantation and home parenteral nutrition: A prospective single‐center pilot study

Pediatric transplantation, 2021-05, Vol.25 (3), p.e13982-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Increased Use of Anti-Tumor Necrosis Factor Following the Implementation of the ECCO-ESPGHAN Guidelines and its Impact on the Outcome of Pediatric Crohn's Disease: A Retrospective Single-Center Study

Journal of pediatric gastroenterology and nutrition, 2022-01, Vol.74 (1), p.79-84

2022

Link zum Volltext

Verfügbarkeit prüfen

Aortic Intima‐Media Thickness as an Early Marker of Atherosclerosis in Children With Inflammatory Bowel Disease

Journal of pediatric gastroenterology and nutrition, 2015-07, Vol.61 (1), p.41-46

2015

Link zum Volltext

Verfügbarkeit prüfen

Histologic findings at diagnosis as predictive markers of clinical outcome in pediatric ulcerative colitis

Digestive and liver disease, 2024-01, Vol.56 (1), p.106-111

2024

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic accuracy of multimodal noninvasive follow‐up for pediatric ulcerative colitis: A single‐center prospective study

Journal of pediatric gastroenterology and nutrition, 2024-02, Vol.78 (2), p.280-288

2024

Link zum Volltext

Verfügbarkeit prüfen

Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy

Digestive and liver disease, 2015-06, Vol.47 (6), p.455-459

2015

Link zum Volltext

Verfügbarkeit prüfen

Is Fecal Calprotectin a Useful Marker for Small Bowel Crohn's Disease?

Journal of pediatric gastroenterology and nutrition, 2021-04

2021

Link zum Volltext

Verfügbarkeit prüfen

Increased Use of Anti‐Tumor Necrosis Factor Following the Implementation of the ECCO–ESPGHAN Guidelines and its Impact on the Outcome of Pediatric Crohn's Disease

Journal of pediatric gastroenterology and nutrition, 2022-01, Vol.74 (1), p.79-84

2022

Link zum Volltext

Verfügbarkeit prüfen

Su2021 - Mucosal Healing and Histological Remission in Pediatric Ulcerative Colitis: Does the Target Change the Outcomes?

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-668-S-668

2018

Link zum Volltext

Verfügbarkeit prüfen

Disease course and efficacy of medical therapy in stricturing paediatric Crohn's disease

Digestive and liver disease, 2013-06, Vol.45 (6), p.464-468

2013

Link zum Volltext

Verfügbarkeit prüfen

Su2019 - A Treat-To Target Strategy Guided by Pan-Enteric Evaluation in Children with Crohn's Disease Improves Outcomes at 2 Years

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-668-S-668

2018

Link zum Volltext

Verfügbarkeit prüfen

Disease course of ulcerative proctitis in children: A population-based study on behalf of the SIGENP IBD Group

Digestive and liver disease, 2024-01, Vol.56 (1), p.70-76

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(72)
Berichte
(2)

Sprache

Englisch
(74)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Factors associated with quality of life in Italian children and adolescents with IBD

Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD Registry

Treat-to-Target in Pediatric Inflammatory Bowel Disease: What Does the Evidence Say?

Safety of Biological Therapy in Children With Inflammatory Bowel Disease

Natural History of Anemia and Efficacy and Safety of Oral Iron Therapy in Children Newly Diagnosed With Inflammatory Bowel Disease

Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease

Is Fecal Calprotectin a Useful Marker for Small Bowel Crohn Disease?

A Treat-to-Target Strategy Guided by Pan-Enteric Evaluation in Children With Crohn’s Disease Improves Outcomes at 2 Years

Predictors of Long‐term Clinical and Endoscopic Remission in Children With Crohn Disease Treated With Infliximab

Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN

Inflammatory Bowel Disease-Unclassified in Children: Diagnosis and Pharmacological Management

Mucosal healing in Crohn's disease: new insights

Quality of life in long term survivors of pediatric intestinal transplantation compared with liver transplantation and home parenteral nutrition: A prospective single‐center pilot study

Increased Use of Anti-Tumor Necrosis Factor Following the Implementation of the ECCO-ESPGHAN Guidelines and its Impact on the Outcome of Pediatric Crohn's Disease: A Retrospective Single-Center Study

Aortic Intima‐Media Thickness as an Early Marker of Atherosclerosis in Children With Inflammatory Bowel Disease

Histologic findings at diagnosis as predictive markers of clinical outcome in pediatric ulcerative colitis

Diagnostic accuracy of multimodal noninvasive follow‐up for pediatric ulcerative colitis: A single‐center prospective study

Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy

Is Fecal Calprotectin a Useful Marker for Small Bowel Crohn's Disease?

Increased Use of Anti‐Tumor Necrosis Factor Following the Implementation of the ECCO–ESPGHAN Guidelines and its Impact on the Outcome of Pediatric Crohn's Disease

Su2021 - Mucosal Healing and Histological Remission in Pediatric Ulcerative Colitis: Does the Target Change the Outcomes?

Disease course and efficacy of medical therapy in stricturing paediatric Crohn's disease

Su2019 - A Treat-To Target Strategy Guided by Pan-Enteric Evaluation in Children with Crohn's Disease Improves Outcomes at 2 Years

Disease course of ulcerative proctitis in children: A population-based study on behalf of the SIGENP IBD Group

Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group

Suchergebnisse filtern